JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today [...] Read more »
Ittihad announces Half Year 2024 Financial Results
ABU DHABI, United Arab Emirates, Sept. 04, 2024 (GLOBE NEWSWIRE) — Ittihad International Investment LLC ("Ittihad"; the "Company"), the leading industrial conglomerate in the UAE, today announces its Half Year 2024 [...] Read more »
Yili Reports FY2024 H1 Revenue of 59.9 Billion Yuan with 19% YoY Growth in Net Profit Attributable to the Parent Company
HOHHOT, China, Sept. 02, 2024 (GLOBE NEWSWIRE) — On August 29, Yili Group (600887.SS) released its FY2024 H1 report. During the reporting period, the company continued to solidify its industrial leadership with a total revenue of [...] Read more »
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
JERUSALEM , Aug. 09, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, [...] Read more »
Quantexa, société primée en intelligence décisionnelle accélère sa dynamique mondiale et annonce de solides résultats financiers pour l'exercice fiscal 2024
- Quantexa devrait atteindre 100 millions de dollars de revenu annuel récurrent (ARR) [...] Read more »
Preisgekröntes Decision Intelligence-Unternehmen Quantexa beschleunigt globale Dynamik und meldet starke Geschäftsergebnisse für das Geschäftsjahr 2024
- Quantexa wird bis Ende 2024 einen ARR von 100 Mio. USD erzielen, angetrieben durch den wachsenden [...] Read more »
Award-Winning Decision Intelligence Firm Quantexa Accelerates Global Momentum, Announces Strong FY24 Business Results
- Quantexa set to achieve $100M in ARR by end of 2024, fueled by the growing Decision Intelligence [...] Read more »
Ittihad announces Full Year 2023 Financial Results
ABU DHABI, United Arab Emirates, May 17, 2024 (GLOBE NEWSWIRE) — Ittihad International Investment LLC (Ittihad), the leading industrial conglomerate in the UAE, today announces its Full Year 2023 Financial Results.
Read more »
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial [...] Read more »
Entera Bio Reports Q3 2023 Financial Results, Highlights Transformational Steps and Unveils Vision as Premier Oral Peptide Company with Five Potential Programs in Development
JERUSALEM, Nov. 14, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), ("Entera" or the "Company"), a leader in the development of orally delivered peptides and small therapeutic proteins, [...] Read more »
Lifezone Metals Announces Publication of H1 2023 Financial Results and Shareholder Letter
New York (United States), Sept. 20, 2023 (GLOBE NEWSWIRE) — Lifezone Metals Limited ("Lifezone Metals" or the "Company") (NYSE: LZM), a modern metals company creating value across the battery metals supply chain [...] Read more »
[INVNT GROUP]™ achieves record global growth, accelerating history-making brand campaigns, strategic partnerships, and humanitarian work.
New York, NY, May 11, 2023 (GLOBE NEWSWIRE) — [INVNT GROUP] THE GLOBAL BRANDSTORY PROJECT and leading agency portfolio of complementary brand storytelling disciplines, continues its explosive growth trajectory and worldwide [...] Read more »
Cellebrite Announces First-Quarter 2023 Results
Revenue of $71.2 million, 14% year–over–year increase due primarily to
27% growth in subscription revenue;
ARR of $261.3 million, up 30% [...] Read more »
Entera Bio Announces Q1 2023 Financial Results and Corporate Updates
JERUSALEM, May 05, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides and therapeutic proteins, today [...] Read more »
Entera Bio Provides 2022 Corporate Milestones and Financial Results for the Year Ended December 31, 2022
JERUSALEM, March 31, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides and therapeutic proteins, today [...] Read more »